The Hepatitis Foundation International global initiatives aim to continue to facilitate international knowledge exchange with a focus on four key areas:
- Prevention & Awareness
- Research & Surveillance
All of our programs and services serve to impact global policy, provide technical assistance and bridge the gap toward viral hepatitis elimination globally. To collaborate with us email firstname.lastname@example.org.
The Hepatitis Foundation International, while utilizing its global experience, partnerships and strategic capabilities has now launched Global Access Now™, a program through which HFI brings together stakeholders to find solutions that will bring lifesaving, curative medication to those in need. READ MORE
Over the last two decades, the Hepatitis Foundation International through its extensive outreach programs, services and resources has reached constituents and communities worldwide.
Hepatitis is an inflammation of the liver, most commonly caused by a viral infection. There are five main hepatitis viruses, referred to as types A, B, C, D and E. These five types are of greatest concern because of the burden of illness and death they cause and the potential for outbreaks and epidemic spread. In particular, types B and C lead to chronic disease in hundreds of millions of people and, together, are the most common cause of liver cirrhosis and cancer. READ MORE
Viral hepatitis is inflammation of the liver caused by a virus. There are five different hepatitis viruses, hepatitis A, B, C, D and E.
All of these viruses cause short term, or acute infection. However the hepatitis B, C and D viruses can also cause long-term infection, called chronic hepatitis, which can lead to life-threatening complications such as cirrhosis (liver scarring), liver failure, and liver cancer. Viral hepatitis kills 1.4 million people every year. READ MORE
Hepatitis C Mortality Rates
The global burden of viral hepatitis from 1990 to 2013:
Findings from the Global Burden of Disease Study 2013
Infectious viral hepatitis is an important challenge to health worldwide. Hepatitis A virus (HAV) and hepatitis E virus (HEV) are endemic in many low-income countries.1,2 They usually cause self-limiting hepatitis but occasionally lead to fulminant liver failure and, in rare cases of immunosuppression, chronic HEV infection. Hepatitis B
virus (HBV) and hepatitis C virus (HCV) also cause acute illness but more commonly lead to progressive liver fibrosis, cirrhosis, and an increased risk of liver cancer (specifically hepatocellular carcinoma). READ MORE